Evidence map›Paper›PMID 35453944›Full record

ReviewDiagnostics (Basel, Switzerland)2022

Role of Cardiac Imaging Modalities in the Evaluation of COVID-19-Related Cardiomyopathy.

Antonella Cecchetto, Stefano Nistri, Giulia Baroni, Gianpaolo Torreggiani, Patrizia Aruta, Valeria Pergola, Anna Baritussio, Marco Previtero, Chiara Palermo, Sabino Iliceto and 1 more

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Antonella CecchettoDepartment of Cardiac Thoracic Vascular Sciences and Public Health, University of Padua Medical School, 35128 Padova, Italy.ORCID 0000-0003-4069-4177
Stefano NistriDepartment of Cardiology, CMSR, Altavilla Vicentina, 36077 Vicenza, Italy.
Giulia BaroniDepartment of Cardiac Thoracic Vascular Sciences and Public Health, University of Padua Medical School, 35128 Padova, Italy.
Gianpaolo TorreggianiDepartment of Cardiac Thoracic Vascular Sciences and Public Health, University of Padua Medical School, 35128 Padova, Italy.
Patrizia ArutaDepartment of Cardiac Thoracic Vascular Sciences and Public Health, University of Padua Medical School, 35128 Padova, Italy.
Valeria PergolaDepartment of Cardiac Thoracic Vascular Sciences and Public Health, University of Padua Medical School, 35128 Padova, Italy.ORCID 0000-0002-3317-7342
Anna BaritussioDepartment of Cardiac Thoracic Vascular Sciences and Public Health, University of Padua Medical School, 35128 Padova, Italy.
Marco PreviteroDepartment of Cardiac Thoracic Vascular Sciences and Public Health, University of Padua Medical School, 35128 Padova, Italy.
Chiara PalermoDepartment of Cardiac Thoracic Vascular Sciences and Public Health, University of Padua Medical School, 35128 Padova, Italy.
Sabino IlicetoDepartment of Cardiac Thoracic Vascular Sciences and Public Health, University of Padua Medical School, 35128 Padova, Italy.
Donato MeleDepartment of Cardiac Thoracic Vascular Sciences and Public Health, University of Padua Medical School, 35128 Padova, Italy.ORCID 0000-0002-2823-4090
University of Padua · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiac involvement has been described during the course of SARS-CoV-2 disease (COVID-19), with different manifestations. Several series have reported only increased cardiac troponin without ventricular dysfunction, others the acute development of left or right ventricular dysfunction, and others myocarditis. Ventricular dysfunction can be of varying degrees and may recover completely in some cases. Generally, conventional echocardiography is used as a first approach to evaluate cardiac dysfunction in patients with COVID-19, but, in some cases, this approach may be silent and more advanced cardiac imaging techniques, such as myocardial strain imaging or cardiac magnetic resonance, are necessary to document alterations in cardiac structure or function. In this review we sought to discuss the information provided by different cardiac imaging techniques in patients with COVID-19, both in the acute phase of the disease and after discharge from hospital, and their diagnostic and prognostic role. We also aimed at verifying whether a specific form of cardiac disease due to the SARS-CoV-2 can be identified.

Indexed as

cardiac diseasecardiac imagingCOVID-19

Identifiers

PMID35453944
PMCPMC9025970
OpenAlexW4224324939

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.